1.
|
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSMS995AUS38, STOP Trial, NCT00050635
|
|
2.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: NeuroendoUnit-4, NCT00495846
|
|
3.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-94133A1, NCI-V95-0664
|
|
4.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-E1295, CLB-9770, SWOG-E1295, NCI-P97-0081, NCT00003057
|
|
5.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-N00CA, NCI-P02-0221, N00CA, NCT00033605
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-874652, MAYO-874652, NCCTG-87-46-52
|
|
7.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: NCI-89-C-80, NCI-T89-0090N, T89-0090
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: postmenopausal
Sponsor: NCI
Protocol IDs: NCCTG-893253, MAYO-893253, MCGILL-ET-9110, NCCTG-89-32-53
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: NCCTG-894352, MAYO-894352, NCCTG-89-43-52
|
|
10.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-0315, NCT00075868
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-N04C2, NCT00182754
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 85
Sponsor: Other
Protocol IDs: HCC-327-2000, NCT00121914
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CRAD001C2325, NCT00412061
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: NCI
Protocol IDs: SWOG-S0518, S0518, NCT00569127
|
|
15.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSMS995AIC04, NCT00582426
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: postmenopausal
Sponsor: Other
Protocol IDs: MA14, CAN-NCIC-MA14, NCI-V96-1060, CDR0000065135, NCT00002864
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-947851, NCT00002779, NCCTG-94-78-51
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-917202, NCI-V96-1073
|
|
19.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-87094, NCI-V88-0389
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and older
Sponsor: NCI
Protocol IDs: NCCTG-898251, MAYO-898251, NCCTG-89-82-51
|
|
21.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 15 to less than 71
Sponsor:
Protocol IDs: MDA-ID-89003, NCI-V89-0131
|
|
22.
|
Phase: Phase II
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-90161, NCI-V91-0041
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MGH-88-7553, NCI-V92-0042
|
|
24.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-922051, NCCTG-92-20-51
|
|
25.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NIDDK
Protocol IDs: 880194, 88-DK-0194, NCT00001228
|
Mobile | Español
